Close

Orexigen (OREX) Plans Resubmission of Contrave NDA by Year End 2013

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. LVS
2. TSM
3. SPY
4. NFLX
5. CSX
6. UAL
7. ALK
8. EFX
9. TSLA
10. INFY


Go back to Orexigen (OREX) Plans Resubmission of Contrave NDA by Year End 2013
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Delayed: 99.98 --0 (-0%)
Previous Close $99.98    52 Week High $2.68 
Open $99.98    52 Week Low $1.30 
Day High $99.98    P/E N/A 
Day Low $99.98    EPS $-0.08 
Volume 67,623       

Orexigen Therapeutics, Inc. (NASDAQ: OREX) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $4.75 
Open $0.04    52 Week Low $0.35 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $-1.02 
Volume 74,385       

Vivus, Inc. (NASDAQ: VVUS) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $1.85 
Open $44.85    52 Week Low $0.92 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $-2.13 
Volume 1,328